The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 10, 2024
Filed:
Jan. 26, 2023
Applicant:
Incyte Corporation, Wilmington, DE (US);
Inventors:
Oleg Vechorkin, Wilmington, DE (US);
Minh Nguyen, Claymont, DE (US);
Chao Qi, Newark, DE (US);
Anlai Wang, Wilmington, DE (US);
Michael Witten, Philadelphia, PA (US);
Yao Xu, Wilmington, DE (US);
Hai Fen Ye, Newark, DE (US);
Ke Zhang, Wilmington, DE (US);
Peng Zhao, Newark, DE (US);
Wenqing Yao, Chadds Ford, PA (US);
Assignee:
Incyte Corporation, Wilmington, DE (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5377 (2006.01); A61K 31/437 (2006.01); A61K 31/496 (2006.01); A61K 31/4995 (2006.01); A61P 35/00 (2006.01); C07D 471/04 (2006.01); C07D 519/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5377 (2013.01); A61K 31/437 (2013.01); A61K 31/496 (2013.01); A61K 31/4995 (2013.01); A61P 35/00 (2018.01); C07D 471/04 (2013.01); C07D 519/00 (2013.01);
Abstract
The present invention relates to bicyclic heterocycles, and pharmaceutical compositions of the same, that are inhibitors of the FGFR enzyme and are useful in the treatment of FGFR-associated diseases such as cancer.